April 15th 2024
Drug Topics sat down with Sally Rafie, founder of Birth Control Pharmacist, to discuss how pharmacists are well positioned to expand access to reproductive care.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Positive Results Seen with Nutraceutical Supplement for Hair Growth in Women
July 19th 2022Perimenopausal, menopausal, and postmenopausal women experienced a progressive improvement in hair growth, shedding, quality of life, and menopausal symptoms after 12 months with an active nutraceutical supplement.
Treating Vulvovaginal Candidiasis with Ibrexafungerp
May 24th 2022In June 2021, ibrexafungerp (Brexafemme; Scynexis) became the first drug approved by the U.S. Food and Drug Administration (FDA) in a novel antifungal class in more than 20 years and is now available to treat vulvovaginal candidiasis (VVC).
Safety, Efficacy of Combined Oral Contraceptives for RA Reviewed
February 14th 2022While the use of combined oral contraceptives in patients with rheumatoid and autoimmune disorders have focused on safety, a recent narrative review highlighted the efficacy and benefits of these contraceptives in women with RA.